Development of Novel Membrane Disrupting Lipoguanidine Compounds Sensitizing Gram-Negative Bacteria to Antibiotics

Authors:
Open Access
Publisher website
Google Scholar
Abstract
A new class of amphiphilic molecules, the lipoguanidines, designed as hybrids of guanidine and fatty acid compounds, has been synthesized and developed. The new molecules present both a guanidine polar head and a lipophilic tail that allow them to disrupt bacterial membranes and to sensitize Gram-negative bacteria to the action of the narrow-spectrum antibiotics rifampicin and novobiocin. The lipoguanidine 5g sensitizes Klebsiella pneumonia, Acinetobacter baumannii, Pseudomonas aeruginosa, and Escherichia coli to rifampicin, thereby reducing the antibiotic minimum inhibitory concentrations (MIC) up to 256-fold. Similarly, 5g is able to potentiate novobiocin up to 64-fold, thereby showing a broad spectrum of antibiotic potentiating activity. Toxicity and mechanism studies revealed the potential of 5g to work synergistically with rifampicin through the disruption of bacterial membranes without affecting eukaryotic cells.
Funding Information
  • Royal Society (IEC\R2\202028)
  • Department of Health and Social Care (111742)
  • Chinese Government Scholarship (202008060037)
  • H2020 Marie Sklodowska-Curie Actions (101027065)
  • National Centre for the Replacement Refinement and Reduction of Animals in Research (NC/T001240/1)
  • Biotechnology and Biological Sciences Research Council (BB/M009513/1)
  • National Research Foundation

This publication has 43 references indexed in Scilit: